Skip to content

Evonik Industries
Search Search

Skip over generic navigation

  • www.evonik.com

Skip over primary navigation

EUDRAGIT® | HOMEEUDRAGIT® | HOME
  • About EUDRAGIT®About EUDRAGIT®
  • Products & servicesProducts & services
  • Workshops & eventsWorkshops & events
  • DownloadsDownloads
  • e-Labe-Lab
  • ContactContact

Skip over visual

Skip over functional column



Skip over functional column

EUDRAGIT® Functional Polymers for Protective, Enteric and Sustained-Release Formulations

  • About EUDRAGIT®
  • Business model

Our business model

 

Pharma Polymers Value Contribution

Enlarge picture

With its Pharma Polymers product line, Evonik is a leading provider of functional pharmaceutical excipients and advanced formulation solutions. Providing a broad range of polymer products, combined with high quality pharmaceutical services we are a strategic resource for the health care industry for the design and development of pharmaceutical formulations and medical devices. Using us as a source for your drug developments can both reduce risks and increase speed to market.

Based on our well-known EUDRAGIT® product portfolio, we develop coatings and matrix systems that provide reliable and targeted controlled release of active pharmaceutical ingredients from oral dosage forms. Main functionalities are delayed and extended release as well as moisture protection, taste masking and solubility enhancement.

In March 2011 our oral drug delivery platform was complemented by the addition of the RESOMER® polymers which are used for depot formulations and bioresorbable implants as well as in medical devices. Their high level of purity and their excellent mechanical properties provide a comprehensive basis for innovative and patient friendly applications.

We support your development projects all over the world with 50+ formulations experts in our state-of-the-art equipped laboratories located in Germany, USA, India, China, Japan and Argentina. Our development services include all steps from early feasibility studies to large scale production transfer, including clinical supply manufacturing and scale-up support. To support your quality and development processes, as well as your regulatory submission processes, we provide comprehensive data packages as service for our customers.

Beyond that Evonik Pharma Polymers has developed proprietary technologies to enable superior therapeutic success. They include various technology platforms for bioavailability enhancement as well as customized polymer developments. All technologies offer high performance and attractive line extension options.

  • EUDRAGIT® products
  • Technical support
  • Formulation development
  • GMP services
  • Proof of concept
  • Advanced drug delivery
 

Overview

Business model
News

Overview

EUDRAGIT® products
  • Enteric formulations
    • EUDRAGIT® L 30 D-55
    • EUDRAGIT® L 100-55
    • EUDRAGIT® L 100
    • EUDRAGIT® L 12,5
    • EUDRAGIT® S 100
    • EUDRAGIT® S 12,5
    • EUDRAGIT® FS 30 D
  • Protective formulations
    • EUDRAGIT® E 100
    • EUDRAGIT® E 12,5
    • EUDRAGIT® E PO
  • Sustained-release formulations
    • EUDRAGIT® RL 100
    • EUDRAGIT® RL PO
    • EUDRAGIT® RL 30 D
    • EUDRAGIT® RL 12,5
    • EUDRAGIT® RS 100
    • EUDRAGIT® RS PO
    • EUDRAGIT® RS 30 D
    • EUDRAGIT® RS 12,5
    • EUDRAGIT® NE 30 D
    • EUDRAGIT® NE 40 D
    • EUDRAGIT® NM 30 D
  • PlasACRYL™ T20
Technical support
  • Laboratories worldwide
    • Laboratories in China
    • Laboratories in Germany
    • Laboratories in India
    • Laboratories in Japan
    • Laboratories in the USA
Formulation development
GMP services
  • GMP facilities in Germany
Proof of concept
Advanced drug delivery

Overview

Workshops
Trade shows
Webinars

Overview

Pharma Polymers News
EUDRAGIT® Quickstarts
Brochures
Scientific posters
Product specifications
Other downloads

Overview

Open the e-Lab
What is the e-Lab?
 
  • Contact
  • Sitemap
  • Company information
  • Legal notice
  • Privacy policy
  • Print
  • Send this page